Fig. 7From: Anti-osteosarcoma effect of antiserum against cross antigen TPD52 between osteosarcoma and Trichinella spiralisDetection of apoptosis after treatment with anti-TPD52 antiserum. Western blot was used to detect the expression of apoptosis-related proteins (a). Detection of BCL-2 expression in osteosarcoma by immunohistochemistry (×400). Scale bars: 5 µm (b). BCL-2 expression was quantified using ImageJ software (c). NC: untreated control. PBS: osteosarcoma model. NS: negative serum. TS: 100 µg anti-T. spiralis antiserum. 25 μg, 50 μg and 100 μg: anti-TPD52 antiserum (**P < 0.001; ****P < 0.0001; ns: non-significant)Back to article page